Insight on Pharmaceuticals and Healthcare in Europe

Published within

« | 1 | 2 | 3 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness

This report assesses the current landscape of and future opportunities for therapeutic vaccines outside cancer, covering therapeutic vaccine approaches in cardiovascular and metabolic, CNS, autoimmune and infectious diseases.

Published By Datamonitor
17 Dec 2009 $3800
Buy
Report
Report

Stakeholder Opinions: Skin and Soft Tissue Infections - The end of the reign of vancomycin

This report gives a comprehensive overview of trends in epidemiology, diagnosis, treatment and referral patterns for skin and soft tissue infections (SSTIs). It discusses the challenges, opportunities and future developments for the SSTI drug market.

Published By Datamonitor
16 Jul 2009 $3800
Buy
Report
Report

Stakeholder Opinions: Sexual Dysfunction - The quest for the new Viagra continues

Examination of the key issues in the treatment of sexual dysfunction, including risk factors, estimates of patient potential, overview of current and pipeline treatments, unmet needs, analysis of commercial opportunities and key stakeholder opinions.

Published By Datamonitor
04 Mar 2010 $7600
Buy
Report
Report

Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity

Datamonitor surveyed 183 rheumatologists in the seven major markets to gain insight into rheumatoid arthritis diagnosis, patient segmentation, current and future prescribing patterns, factors influencing decision making and key treatment challenges.

Published By Datamonitor
17 Sep 2010 $15200
Buy
Report
Report

Russia Pharmaceutical Market Overview - Pharma companies target Russia despite the challenges it presents

Overview of the Russian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
23 Nov 2010 $7600
Buy
Report
Report

R&D Trends: Women's Health - Investment needed to address lack of innovation

Review of key trends in the development of new women’s health drugs across the seven major markets with particular emphasis on contraception, menopausal symptoms, endometriosis, uterine fibroids, infertility, and female sexual dysfunction.

Published By Datamonitor
05 Dec 2011 $3800
Buy
Report
Report

R&D Trends: Chronic Nociceptive Pain – Abundance fails to be matched by innovation

Review of key trends in the chronic nociceptive pain pipeline. Includes a detailed analysis of clinical trial design, target product profile, innovative early-stage approaches and future treatment developments.

Published By Datamonitor
21 Sep 2012 $3800
Buy
Report
Report

Product Profiles: Psoriasis – Novel therapies raise the bar for biologics

This report analyzes key marketed and pipeline agents for psoriasis, including the current market dynamics of topical, oral and biologic products, key lifecycle management strategies, as well as clinical trial data from 2011 dermatology conferences.

Published By Datamonitor
23 Nov 2011 $11400
Buy
Report
Report

Product Profiles: Prostate Cancer – Recent approvals create competitive environment for new market entrants

Analysis of current market dynamics for the treatment of prostate cancer. The report assesses comparator therapies for prostate cancer, identifies key strategies for drug development, and analyzes commercial and clinical potential of pipeline drugs.

Published By Datamonitor
02 Sep 2011 $11400
Buy
Report
Report

Product Profiles: Osteoporosis - Novel candidates offer the greatest potential

In depth analysis of key brands and pipeline agents indicated for the treatment of osteoporosis. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
14 Dec 2011 $11400
Buy

« | 1 | 2 | 3 | » »|

No help is available.